Alberto Cipriani
Overview
Explore the profile of Alberto Cipriani including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
136
Citations
1680
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Corrado D, Graziano F, Bauce B, Bueno Marinas M, Calore C, Celeghin R, et al.
Eur Heart J Suppl
. 2025 Feb;
27(Suppl 1):i73-i82.
PMID: 39980775
The newly proposed classification of cardiomyopathies, referred to as 'the Padua Classification', is based on both pathobiological basis (genetics, molecular biology, and pathology) and clinical features (morpho-functional and structural ventricular...
2.
Porcari A, Razvi Y, Cappelli F, Nitsche C, Serenelli M, Longhi S, et al.
JAMA Cardiol
. 2025 Jan;
PMID: 39841451
Importance: Patients with transthyretin (ATTR) cardiac amyloid infiltration are increasingly diagnosed at earlier disease stages with no heart failure (HF) symptoms and a wide range of cardiac amyloid infiltration. Objective:...
3.
De Michieli L, Sinigiani G, Nistri S, Cipriani A
Eur Heart J Imaging Methods Pract
. 2024 Dec;
2(3):qyae114.
PMID: 39679325
No abstract available.
4.
Argiro A, Zampieri M, Mazzoni C, Fumagalli C, Baccini M, Mattei A, et al.
ESC Heart Fail
. 2024 Dec;
PMID: 39665521
Aims: This study aimed to evaluate the change of the main electrocardiographic (ECG) characteristics and their prognostic role across the main subtypes of cardiac amyloidosis [light-chain amyloidosis (AL) and hereditary...
5.
Porcari A, Chimenti C, Merlo M, Musca F, Vergaro G, Iacoviello M, et al.
G Ital Cardiol (Rome)
. 2024 Nov;
25(12):900-920.
PMID: 39588628
The perspective on cardiac amyloidosis has deeply changed over the last 10 years following major advances in diagnosis and treatment options. This heterogeneous disease requires the interaction among experts of...
6.
Pittorru R, De Lazzari M, Migliore F, Frasson E, Zorzi A, Cipriani A, et al.
J Clin Med
. 2024 Oct;
13(19).
PMID: 39407735
Left ventricular non-compaction (LVNC) is a rare heart muscle disease defined by the presence of prominent left ventricular trabeculation, deep intertrabecular recesses, and a thin compact layer. Several hypotheses have...
7.
Graziano F, Zorzi A, Ungaro S, Bauce B, Rigato I, Cipriani A, et al.
Rev Cardiovasc Med
. 2024 Oct;
25(9):348.
PMID: 39355594
Arrhythmogenic cardiomyopathy (ACM) is a cardiac disease featured by non-ischemic myocardial scarring linked to ventricular electrical instability. As there is no single gold-standard test, diagnosing ACM remains challenging and a...
8.
Corrado D, Zorzi A, Bauce B, Rigato I, Cipriani A, Perazzolo Marra M, et al.
G Ital Cardiol (Rome)
. 2024 Sep;
25(10):735-746.
PMID: 39342558
Arrhythmogenic cardiomyopathy (CMA) is a cardiac disease characterized by non-ischemic ventricular scarring and electrical instability. The diagnosis of CMA still remains challenging today and requires the use of a set...
9.
Graziano F, Zorzi A, Cipriani A, Bauce B, Rigato I, Perazzolo Marra M, et al.
Trends Cardiovasc Med
. 2024 Sep;
35(2):107-113.
PMID: 39341581
Arrhythmogenic Cardiomyopathy (ACM) is a cardiac disorder characterized by non-ischemic myocardial scarring, which may lead to ventricular electrical instability and systolic dysfunction. Diagnosing ACM is challenging as there is no...
10.
Corrado D, Thiene G, Bauce B, Calore C, Cipriani A, De Lazzari M, et al.
Int J Cardiol
. 2024 Sep;
418:132571.
PMID: 39306295
Over the last 20 years, the scientific progresses in molecular biology and genetics in combination with the increasing use in the clinical setting of contrast-enhanced cardiac magnetic resonance (CMR) for...